Abstract
ABSTRACT Purpose To estimate the prevalence of vision loss for 2020 in South and Central Asia and analyze trends since 1990. Methods In a systematic literature review, we estimated the prevalence of blindness, visual impairment (VI) and presbyopia-related VI in 1990,2000,2010, and 2020. Results The study included 103 population-based studies. In South/Central Asia combined, age-standardized prevalence of blindness, moderate-to-severe VI (MSVI), moderate VI, severe VI, mild VI and presbyopia-related VI for all ages was 0.65% (95% uncertainty interval (UI):0.56/0.74), 5.06 (4.55/5.59), 4.40 (3.91/4.94), 0.65 (0.57/0.74), 3.21 (2.89/3.56), and 8.77 (6.37/11.48), respectively, with higher values for women than men. From 2000 to 2020, changes in age-standardized prevalence in South Asia were −36.85 (−36.94/−36.76), −7.01 (−7.13/−6.90), −5.86 (−5.99/−5.73), −13.96 (−14.09/−13.82), −9.55 (−9.66/−9.44), and −8.62 (−8.93/−8.31), respectively for men, and −38.50 (−38.59/−38.40), −10.12 (−10.22/−10.01), −9.23(−9.36/−9.10), −14.86 (−14.99/−14.73), −9.44 (−9.56/−9.33), and −7.78 (−8.09/−7.48), respectively for women. From 2000/2020, the changes in age-standardized prevalence figures in Central Asia were −21.44 (−21.58/−21.30), −2.75 (−2.87/−2.64), −2.17 (−2.30/−2.04), −7.12 (−7.26/−6.99), −5.36 (−5.48/−5.25), and −3.67(−4.02/−3.32), respectively for men, and −21.13 (−21.27/−20.99), −2.70 (−2.81/−2.58), −2.18 (−2.30/−2.05), −6.93 (−7.07/−6.80), −5.03 (−5.14/−4.91), and −2.65 (−3.00/−2.30), respectively, for women. In 2020, 11.94 million (9.98–14.07) and 0.30 million (0.24–0.36) individuals were blind, and 96.22 million (84.12–110.27) and 2.95 million (2.52–3.43) had MSVI in South Asia and Central Asia, respectively. Conclusions Despite a higher decrease between 2000 and 2020, the age-standardized prevalence of blindness and MSVI were higher in South Asia than in Central Asia in 2020. The number of people affected increased due to population growth and improved longevity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
